Литература
1. Johnson А.Е Beneath the technological fix Outliers and probability statements. J Chron Dis 1985;38:957-961.
2 The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
New EnglJ Med 1993;329:673-682.3. Farkouh M.E., Lang J.D., Sackett D.L. Thrombolytic agents: the science of the art of choosing the better treatment. Ann Intern Med 1994;120:886-888.
4. Raschke R.A., Reilly B.M., Guidry J.R., Fontana J.R., Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993;119:874-881.
5. Peto R., Pike M.C., Armitage R1 Breslow N.E., Cox D.R, Howard S.V., Mantel N., McPherson K., Peto J., Smith PG Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 1. Introduction and design BrJ Cancer 1976;34 585-612
6 Giardiello EM., Hamilton S.R., Krush AJ., Piantadosi S., Hylind LM., Celano P, Booker S.V., Robinson C.R., Offerhaus G.J.A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New EnglJ Med 1993;328:1313-1316.
7. Braitman L.E. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991;114:515-517.
8. Eisenberg D.M., Kessler R.C., Foster C., Norlock EE., Calkins D.R., Delbanco T.L. Unconventional medicine in the United States. Prevalence, costs and patterns of use. New EnglJ Med 1993;328:246-252.
9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitis. New EnglJ Med 1993; 329:977-986.
10. Grover S.A., Barkun A.N., Sackett D.L. Does the patient have splenomegaly? JAMA 1993;270:2218-2221.
11. Goodman S.N., Berlin J.A. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994;12Г200-206.
12. Sackett D.L., Haynes R.B., Gent M., Taylor D.W. Compliance. In: Inman WHW1 ed. Monitoring for drug safety, Lancaster, UK: MTP Press, 1980.
13. Armitage P.I. Importance of prognostic factors in the analysis of data from clinical trials. Control Clin Trials 1981;1:347-353.
14. ConcatoJ., Feinstein A.R., Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201-210.
15. Diamond G.A. Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction J Am Coll Cardiol 1989;14:12A-22A.
Рекомендуемая литература
Altman D.G., Gore S.M., Gardner M.J., Pocock S.J. Statistical guidelines for contributors to medical journals. Br MedJ 1983;286:1489-1493.
Bailer J.C. III, Mosteller F, eds. Medical uses of statistics. Waltham, MA: New EnglandJournal of Medicine Books, 1986.
Cupples L.A., Heeren T1 Schatzkin A., Colton T Multiple testing of hypotheses in comparing two groups. Ann Intern Med 1984;100:122-129.
Detsky A.S., Sackett D.L. When was a "negative" clinical trial big enough? How many patients you need depends on what you found. Arch Intern Med 1985;145:709-712.
Carpenter L.M. Is the study worth doing? Lancet 1993;343:221-223.
Datta M. You cannot exclude the explanation you haven’t considered. Lancet 1993;342:345-347.
Glynn J.R. A question of attribution. Lancet 1993;342:530-532.
Grisso J.A. Making comparisons. Lancet 1993;342:157-160.
Jolley T The glitter of the t table. Lancet 1993;342:27-29.
Leon D. Failed or misleading adjustment for confounding. Lancet 1993;342:479-481.
Mertens TE. Estimating the effects of misclassification. Lancet 1993;342:418-421. Sitthi-Amorn C., Poshachinda V. Bias. Lancet 1993;343:286-288.
Victoria C.G.
What's the denominator? Lancet 1993;342:97-99.Friedman G.D. Primer of epidemiology, 4th ed. New York: McGraw-Hill, 1994.
Gardner M.J., Altman D.G. Statistics with confidence-confidence intervals and statistical guidelines. London. BMJ Books, 1989.
Goodman S.N., Berlin J.A. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994;121:200-206.
Hanley J.A., Lipman-Hand A. If nothing goes wrong is everything right? Interpreting zero numerators. JAMA 1983:249:1743.
Hennekens C.H., Buring J.E. Epidemiology in medicine. Boston: Little, Brown & Co. 1987.
Ingelfinger J.A., Mosteller F, Thibodeau L.A., Ware J.H. Biostatistics in clinical medicine. New York: Macmillan 1983.
Moses L.E. Statistical concepts fundamental to investigations. N EnglJ Med 1985;312:890-897.
Riegelman R.K., Hirsch R.P. Studying and study and testing a test. 2nd ed. Boston: Little, Brown & Co. 1989.
Rothman K.J. A show of confidence. N EnglJ Med 1978;299:1362-1363.
Young M.J., Bresnitz E.A., Strom B.L. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med 1983;99:248-251.
Еще по теме Литература:
- Список рекомендуемой литературы Основная литература
- Глава 1. Обзор литературы
- Литература:
- Как читать медицинскую литературу
- Дополнительная литература
- 1.4. Анализ данных литературы и постановка вопроса
- Список литературы и материалов
- Глава I. Обзор литературы
- Литература.
- Литература
- Литература
- Литература
- Литература
- Литература
- Литература
- Литература
- Литература
- Литература
- Литература